glycyrrhizic acid has been researched along with Pulmonary Fibrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Zhou, X | 1 |
| Dai, K; Deng, M; Deng, X; Guo, Y; Hao, C; Lin, J; Niu, Z; Wang, C; Xu, X; Yao, W | 1 |
| Cai, HF; He, LF; Li, X; Wu, ZM; Ye, B; Zhu, ZH | 1 |
| Cao, B; Chen, H; Li, GF; Liu, B; Wang, PL; Wei, F; Wei, LQ; Yu, X; Zhang, D | 1 |
| Hattori, T; Iizuka, S; Miura, A; Mogami, S; Nakazato, M; Tsubouchi, H; Yamada, C; Yanagi, S | 1 |
| Jian, XD; Zhao, Y | 1 |
1 trial(s) available for glycyrrhizic acid and Pulmonary Fibrosis
| Article | Year |
|---|---|
[Clinical effect of compound monoammonium glycyrrhizinate combined with dandelion in treatment of acute paraquat poisoning].
Topics: Bilirubin; Blood Urea Nitrogen; Creatinine; Glycyrrhizic Acid; Humans; Medicine, Chinese Traditional; Multiple Organ Failure; Paraquat; Plant Extracts; Poisoning; Prognosis; Pulmonary Fibrosis; Taraxacum | 2016 |
5 other study(ies) available for glycyrrhizic acid and Pulmonary Fibrosis
| Article | Year |
|---|---|
Anti-histamine effects of dipotassium glycyrrhizinate on lung fibroblasts, implicating its therapeutic mechanism for pulmonary fibrosis.
Topics: Animals; Fibroblasts; Glycyrrhizic Acid; Histamine; Lung; Pulmonary Fibrosis; Rats; Tryptases | 2022 |
Glycyrrhizic Acid Attenuates Pulmonary Fibrosis of Silicosis by Inhibiting the Interaction between HMGB1 and BRG1 through PI3K/Akt/mTOR Pathway.
Topics: Animals; Cell Proliferation; Glycyrrhizic Acid; HMGB1 Protein; Male; Mammals; Mice; Nuclear Proteins; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Signal Transduction; Silicosis; TOR Serine-Threonine Kinases | 2022 |
Glycyrrhizic acid, as an inhibitor of HMGB1, alleviates bleomycin-induced pulmonary toxicity in mice through the MAPK and Smad3 pathways.
Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Female; Glycyrrhizic Acid; HMGB1 Protein; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Pulmonary Fibrosis; Smad3 Protein | 2021 |
Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Cyclooctanes; Cytokines; Drug Synergism; Glycyrrhizic Acid; Lignans; Lung; Male; Mice; NADPH Oxidase 4; Polycyclic Compounds; Pulmonary Fibrosis; Signal Transduction; Smad2 Protein | 2017 |
Rikkunshito ameliorates bleomycin-induced acute lung injury in a ghrelin-independent manner.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Apoptosis; Bleomycin; Disease Models, Animal; Drugs, Chinese Herbal; Eating; Epithelial Cells; Ghrelin; Glycyrrhizic Acid; Hesperidin; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; Pulmonary Alveoli; Pulmonary Fibrosis; Signal Transduction | 2014 |